Press release
PREMIER Biosoft International Releases version 7.50 of AlleleID
Palo Alto, California – September 15, 2009- PREMIER Biosoft International today announced the world wide release of AlleleID version 7.50. AlleleID will now enable xMAP® users to design strain differentiation assays. AlleleID employs a powerful algorithm to first align the sequences and then identify unique regions in each. The capture probes are located in these regions and then checked for multiplexing for use in bead based suspension arrays, based on Luminex's xMAP® technology.In addition to the above, single template assays are also supported wherein oligos are designed for rapid and high-throughput SNP genotyping assays, particularly useful for population studies. It enables use of pre-designed proven oligos and designs a multiplex set compatible with them, saving costs. Included is a database of MicroPlex xTAGs (formerly known as FlexMAP TAGs) for automatic addition of appropriate tags to Allele Specific Primer Extension (ASPE) primers. Users also have the option to tag them on their own.
“AlleleID is now available for xMAP® users identifying strains. We are committed to keeping pace with their needs by constantly adding advanced and powerful features to our products,” commented Kay Brown, V.P. Business Development and Marketing.
For details, please visit: http://www.premierbiosoft.com/bacterial-identification/realtime-PCR/luminex_xMAP.html
About PREMIER Biosoft International:
Founded in 1994, the company is a group of computer scientists and molecular biologists dedicated to producing cutting-edge intuitive software for the molecular biologist. The goal of the company is to study the most recent innovations in molecular biology and translate them into software products that aid biologists. Additional information about PREMIER Biosoft International is available at http://www.PremierBiosoft.com.
Contact:
Arun Apte
PREMIER Biosoft International
650-856-2703
http://www.PremierBiosoft.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release PREMIER Biosoft International Releases version 7.50 of AlleleID here
News-ID: 96838 • Views: …
More Releases for Allele
Genome Editing Market 2020 Specification, Growth Drivers, Industry Analysis Fore …
Genome Editing Market Snapshot:
The global genome editing market was valued at USD 3,933.07 million in 2019 and is expected to grow at 14.5% CAGR during the forecast study period.
Genomic editing refers to the strategies and techniques implemented for modifying any living organism's target genetic information. Genome editing includes gene alteration by recombinant technology in different locations, which improves insertion precision and decreases cell toxicity. The genome editing industry is still in the…
Gene Editing Technology Market May See a Big Move : Major Giants Cellectics, Edi …
Latest released the research study on Global Gene Editing Technology Market, offers a detailed overview of the factors influencing the global business scope. Gene Editing Technology Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Gene Editing Technology Market. The study covers emerging…
Gene Editing Market 2025 | AstraZeneca, Cellectis, Editas Medicine, Dharmacon, Q …
Global Gene Editing Market: Snapshot
Gene editing or genome editing is the targeted insertion or modification of cells in living organism or cells and the method has come to occupy a crucial part of biomedical researches, constantly transforming various disciplines of life sciences. Over the past few years, continuous advancements in gene-editing technologies have led to the advent of several versatile methods, which have enabled investigators to introduce a number…
What's driving the Gene Editing Market trends? CRISPR Therapeutics, Addgene, All …
Market Study Report LLC provides a detailed overview of Gene Editing market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of Gene Editing market in conjunction with the geographical landscape, demand spectrum, remuneration scale, and growth graph of this vertical have also been included in this report.
Genetic technology is still evolving, and research plays an important role in exploring its potential.…
Gene Editing Market 2025 | Qiagen, Sigma-Aldrich, Allele Biotech, Bio Rad, CRISP …
Global Gene Editing Market: Overview
Gene editing involves the insertion, deletion, or replacement of DNA at specific sites in the genome of a cell or an organism. It is usually achieved in a laboratory environment using molecular scissors.
Regulations for the security of life, well-being of plants and animals, human health, and environmental compliance will influence market players for increased focus on import, export, and commercialization of genetically modified organisms (GMOs).
Get Brochure…
Gene Editing Market – Notable Developments 2025 | Qiagen, Sigma-Aldrich, Allel …
Global Gene Editing Market: Overview
Gene editing involves the insertion, deletion, or replacement of DNA at specific sites in the genome of a cell or an organism. It is usually achieved in a laboratory environment using molecular scissors.
Regulations for the security of life, well-being of plants and animals, human health, and environmental compliance will influence market players for increased focus on import, export, and commercialization of genetically modified organisms (GMOs).
Get Brochure…
